Curis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Curis and other ETFs, options, and stocks.

About CRIS

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. 

CEO
James E. Dentzer
CEOJames E. Dentzer
Employees
34
Employees34
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2000
Founded2000
Employees
34
Employees34

CRIS Key Statistics

Market cap
17.50M
Market cap17.50M
Price-Earnings ratio
-0.30
Price-Earnings ratio-0.30
Dividend yield
Dividend yield
Average volume
80.15K
Average volume80.15K
High today
$1.60
High today$1.60
Low today
$1.40
Low today$1.40
Open price
$1.43
Open price$1.43
Volume
71.55K
Volume71.55K
52 Week high
$4.70
52 Week high$4.70
52 Week low
$1.02
52 Week low$1.02

Stock Snapshot

As of today, Curis(CRIS) shares are valued at $1.53. The company's market cap stands at 17.5M, with a P/E ratio of -0.30.

On 2025-11-07, Curis(CRIS) stock moved within a range of $1.40 to $1.60. With shares now at $1.53, the stock is trading +9.3% above its intraday low and -4.4% below the session's peak.

Trading volume for Curis(CRIS) stock has reached 71.55K, versus its average volume of 80.15K.

Over the past 52 weeks, Curis(CRIS) stock has traded between a high of $4.70 and a low of $1.02.

Over the past 52 weeks, Curis(CRIS) stock has traded between a high of $4.70 and a low of $1.02.

People also own

Based on the portfolios of people who own CRIS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.